Answers are grounded in this paper and cite their sources.
3631 Background: African Americans (AA) have a higher incidence and lower survival from colon and rectal cancer than Caucasian Americans (C). Disparities among AA and C have been attributed to multiple factors, including later stage at diagnosis, a higher proportion of poor histopathologic features, inadequate and unequal treatment, and socioeconomic factors. The multidisciplinary management setting provides similarity in management and treatment planning. The objective of this study was to assess pathologic features and survival of CRC in AA and C pts using a large institutional database and comparing national population-based data. Methods: We compiled data from 4,654 patients with colon and rectal cancer treated at Thomas Jefferson University Hospital from 1988-2010 and used Surveillance Epidemiology and End Results registry data from 1988-2004 to compare survival rates. Independent variables included age, racial background, site of primary tumor, differentiation, stage at presentation, recurrence-free survival, and overall survival rates for colon and rectal cancer and for each stage of the disease. We compared survival rates, using statistical modeling to account for disease characteristics between the two groups. Results: At diagnosis, AA pts presented with more advanced stage of disease, were more likely to have proximal disease (p<0.0001), had worse overall 5-year survival, and worse survival stage-by-stage than C pts. The odds ratio for risk of nodal involvement was greater for AA than C pts with lower T-tumors. AA pts were more likely to have less differentiated colon tumors, but more well-differentiated rectal tumors, younger age, and worse survival stage-by-stage than C pts. Although C pts were more likely to have rectal cancer (p<0.0001), they were less likely to have stage IV disease at presentation. Conclusions: AA pts with CRC are more likely to present at a younger age, with later stage, more proximal tumors, have higher nodal involvement with lower T-lesions, and less well differentiated tumors than C. Additional studies on biological features and molecular markers are ongoing and will be presented.
No takes yet. Share an insight, caveat, or question.
Mitchell et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: